This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignees: Beijing Wehand-Bio Pharmaceutical Co., Ltd, Guangxi Wehand-Bio Pharmaceutical Co., Ltd. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 2 Years Active: 2026
Title: Yanmin Chen: Innovator in Pharmaceutical Applications
Introduction
Yanmin Chen is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of polycystic ovarian syndrome (PCOS). His innovative approach utilizes natural extracts to address this common health issue.
Latest Patents
Yanmin Chen holds a patent for the "Use of mulberry twig alkaloids in preparation of drug for treating polycystic ovarian syndrome." This patent describes the use of a mulberry extract in the preparation of a product aimed at treating and improving PCOS. Experimental results demonstrate that mulberry twig alkaloids can reduce ovarian weight in rats with PCOS, improve ovarian pathology, regulate the estrous cycle, and significantly adjust the secretion levels of sex hormones.
Career Highlights
Throughout his career, Yanmin Chen has worked with various pharmaceutical companies, including Beijing Wehand-Bio Pharmaceutical Co., Ltd and Guangxi Wehand-Bio Pharmaceutical Co., Ltd. His work has focused on developing effective treatments for hormonal disorders, showcasing his commitment to advancing medical science.
Collaborations
Yanmin has collaborated with several professionals in his field, including Yuling Liu and Xingang Wang. These partnerships have contributed to the success of his research and the development of innovative treatments.
Conclusion
Yanmin Chen's work in the pharmaceutical industry highlights the potential of natural extracts in treating complex health issues like polycystic ovarian syndrome. His contributions continue to pave the way for future innovations in medical treatments.